Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: thyroid cancer + cancer treatment + cancer  Related to the article below (Last Update: 8/5/2008)

Early screening is crucial to improving recovery rates for breast ...
Orlando Sentinel, FL -
When searching through a family tree for breast cancer, look for family histories of ovarian cancer, thyroid cancer and uterine cancer, which are related to ...
On a 'Re-Mission' to save lives of kids with cancer
USA Today - Aug 3, 2008
By Liz Szabo, USA TODAY Although Rashida Wilkins is only 18, she has already weathered eight years of cancer therapy, including four brain surgeries, ...
OXiGENE Reports Second Quarter 2008 Results
FOXBusiness -
... trial in anaplastic thyroid cancer (ATC) and the Phase II trial of ZYBRESTAT in combination with standard chemotherapy and bevacizumab for the treatment ...OXGN - OTC:CMTX
OxiGene, Inc. Q2 2008 Earnings Call Transcript
Seeking Alpha, NY -
Based on the overall clinical results achieved today with Zybrestat and ATC, and thyroid cancer, we continue to be very optimistic about the prospects for ...OXGN
Health briefs
Tampabay.com, FL -
Thyroid cancer support group: 10:30 am Saturday (second Saturday of every month), Morton Plant Hospital, second floor, Morgan Heart Hospital Multipurpose ...
Exelixis starts thyroid cancer treatment test
Bizjournals.com, NC - Jul 21, 2008
Exelixis Inc. started a late-stage clinical trial of a treatment for medullary thyroid cancer. The South San Francisco company (NASDAQ: EXEL) will test the ...
Exelixis shares rise as late-stage study begins Forbes
Exelixis commences late-stage trial of XL184 to treat medullary ... RTT News
all 23 news articles »  EXEL

Malaysia Star
The science of energy healing
Malaysia Star, Malaysia - Aug 2, 2008
The hospital continues to incorporate qigong as adjuvant cancer therapy and reports satisfactory results in the combined cancer treatment compared to those ...
Future imperfect
Nashua Telegraph, NH - Aug 3, 2008
Those whose chests were radiated are at risk for breast cancer, thyroid cancer and lung cancer; those who received radiation in the pelvic area could suffer ...
Health calendar
Asheville Citizen-Times, NC -
PROSTATE CANCER: Support group for patients and their families, 9:30-11:30 am the third Thursday of the month, 121 Sherwood Road, Asheville. Call 252-4106. ...
Exelixis achieves proof-of-concept for cancer drug
Pharmaceutical Business Review - Jul 30, 2008
... of encouraging Phase I trial data, Exelixis initiated a Phase III registration trial of XL184 for the potential treatment of medullary thyroid cancer. ...EXEL
Source: Google News

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. -
EL Mazzaferri, SM Jhiang - Am J Med, 1994 - ncbi.nlm.nih.gov
... PURPOSE: To determine the long-term impact of medical and surgical treatment
of well differentiated papillary and follicular thyroid cancer. ...

Total thyroidectomy: The Treatment of Choice for patients With Differentiated Thyroid Cancer. -
OH CLARK - Annals of Surgery, 1982 - pubmedcentral.nih.gov
... Abstract. There is considerable controversy about the most appropriate treatment
of patients with thyroid cancer. ... Treatment of thyroid cancer. ...

Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, … -
WM McConahey, ID Hay, LB Woolner, JA van Heerden, … - Mayo Clin Proc, 1986 - ncbi.nlm.nih.gov
... We performed a retrospective study of 859 patients with papillary thyroid cancer,
who had received their primary treatment at the Mayo Clinic during the period ...

… in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment -
DS Cooper, B Specker, M Ho, M Sperling, PW … - Thyroid, 1998 - ncbi.nlm.nih.gov
... suppression and disease progression in patients with differentiated thyroid cancer:
results from the National Thyroid Cancer Treatment Cooperative Registry. ...

Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. … -
PA Singer, DS Cooper, GH Daniels, PW Ladenson, FS … - Archives of Internal Medicine, 1996 - Am Med Assoc
... Treatment guidelines for patients with thyroid nodules and well-differentiated
thyroid cancer. American Thyroid Association. PA Singer ...

[BOOK] Molecular Basis Of Thyroid Cancer -
NR Farid - 2004 - books.google.com
... cancer 107 MARTIN SCHLUMBERGER 6. Growth factors and their receptors in the genesis
and treatment of thyroid cancer 1 2 1 SHEREEN EZZAT 7. Biology ofRas in ...

Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic … -
JD Pineda - Journal of Clinical Endocrinology & Metabolism, 1995 - Endocrine Soc
... Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients
Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment J. Clin ...

Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies -
E Ron, JH Lubin, RE Shore, K Mabuchi, B Modan, LM … - Radiat Res, 1995 - JSTOR
... Individual doses were estimated based on measurements made on an 274. RADIATION-
INDUCED THYROID CANCER anthropomorphic phantom, age at time of treatment and the ...

Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric … -
HR Maxon - Journal of Nuclear Medicine, 1992 - Soc Nuclear Med
... For almost five decades, 131I treatment of thyroid cancer has been based empirically
on administered activity rather than on actual radiation doses delivered. ...

Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer -
EL Mazzaferri, RT Kloos - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc
... Radioiodine therapy refers to the treatment of thyroid cancer within the
thyroid bed and in metastatic sites (91). Surgery is the ...

Source: Google Scholar

Thyroid cancer treatment may be overly aggressive

Last Updated: 2007-08-01 14:12:33 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Thyroid cancers that are clinically insignificant - and may never cause serious disease -- may be treated too aggressively in some patients, according to the author of the 2006 Hayes Martin Lecture, published in the Archives of Otolaryngology-Head and Neck Surgery.

Physicians need to be more selective in how aggressively they evaluate patients who have low-risk thyroid cancer in the earliest stages and stable thyroglobulin levels, Dr. Keith S. Heller told Reuters Health. Elevated or rising levels of thyroglobulin, a protein produced in the thyroid gland, may indicate the presence of thyroid cancer. However, elevated thyroglobulin is also caused by many benign conditions.

Heller from New York University School of Medicine, New York, contends that several of the American Thyroid Association guidelines for the treatment of patients with thyroid nodules or stage 1 thyroid cancer may lead to overly aggressive treatment. In particular, the use of sonography, and how much of a thyroglobulin elevation requires further evaluation, need to be reconsidered.

After reviewing some of the articles that led to these guidelines, Heller asserts: "All of these studies, guidelines, and recommendations lack data that prove that the presence of these minimally involved lymph nodes in any way affects the patient's prognosis." There is also no evidence that the removal or treatment of these lymph nodes improves patients' survival.

"I find these guidelines very troubling for those reasons."

In Heller's personal experience with 360 patients younger than 45 years at the time of initial treatment for differentiated thyroid cancer, 99 percent are still alive. Three died from causes unrelated to thyroid cancer and only one died of thyroid cancer.

Similarly, among 449 of his older patients with previously untreated differentiated thyroid cancer, 91 percent are alive, and of the 40 patients who died, only 8 died of thyroid cancer.

"My objection is not that the guidelines are wrong, but that they need to be clearer in using risk stratification to determine which patients need to be the subject of which guidelines," Heller said.

"In many ways the ability to detect microscopic metastatic thyroid cancer creates a dilemma similar to that faced by urologists when an elevated PSA leads to the detection of microscopic prostate cancer," he pointed out. "Clearly, not all of these need to be treated."

He concludes: "We have embarked on a quixotic quest to rid our patients of microscopic and probably clinically unimportant thyroid cancer. We need to refocus our efforts, not to detect more occult disease, but to identify and cure those few patients whose disease is likely to shorten their lives."

SOURCE: Archives of Otolaryngology-Head and Neck Surgery, July 2007.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.